S3 Figure. Raw images of morphological alterations of E. coli O157:H7 treated with Ib-M1, polymyxin B and streptomycin.

Read full text Summarise with VIRAT
Authors: Mónica Liliana Pérez-Rivera, Ana Elvira Farfán-García, Edgar Javier Rincón Barón, Johanna Marcela Flórez-Castillo, Oscar Gilberto Gomez-Duarte, Indira Paola Hernández
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The Ib-M1 peptide exhibits bactericidal activity against Escherichia coli O157:H7 and low toxicity in mammalian cells. The present study aimed to evaluate the effect of Ib-M1 on E. coli O157:H7 membrane permeabilization. To this end, the minimum inhibitory concentrations of Ib-M1 for E. coli O157:H7 and ML35 were measured. The permeability of the E. coli outer and inner membranes was determined by measuring N-phenyl-1-naphthylamine and O-nitrophenyl-β-galactosidase hydrolysis, respectively after bacterial exposure to antimicrobial peptides and control antibiotics. Morphological changes in antimicrobial-exposed E. coli O157:H7 were evaluated by scanning electron microscopy following treatment with antimicrobial peptides. Ib-M1 demonstrated inhibitory activity against E. coli O157:H7 and ML35 at MICs of 2.9±1.7 and 6.3±0 μM, respectively. The peptide induced permeabilization of the outer membrane of E. coli O157:H7 at all concentrations evaluated, and the permeabilization of the inner membrane after 50 minutes at concentrations between 1xMIC and 8xMIC. The morphological changes induced by Ib-M1 led to significant alterations in bacterial shape including collapsed cells, and pronounced surface roughness and invaginations. In conclusion, physiological and morphological evidence indicate that the Ib-M1 antimicrobial effect against E. coli O157:H7 is mediated by its permeabilizing action on the outer and inner bacterial membranes.

Fields of Study & Subjects

Antimicrobial Peptides and Activities Antimicrobial agents and applications Bacterial Genetics and Biotechnology

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
21 March 2026
Language
EN